During the past decade, S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" are "Acute Lymphoblastic Leukemia" (2 trials), "Acute Myeloid Leukemia" (2 trials), "BCR-ABL Positive" (2 trials), "Leukemia" (2 trials) and "ALL Ph Positive" (1 trials). Many other conditions were trialed in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" in a lesser frequency.

Most popular intervention types in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" are "Drug" (14 trials), "Other" (3 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Allogeneic SCT or Autologous SCT" (1 trials), "Allogeneic stem cell transplantation" (1 trials), "Azacitidine" (1 trials), "Bendamustine" (1 trials) and "Chemotherapy + Blinatumomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena" are 20 trials for "All" genders.

Currently, there are NaN active trials in "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".